Covance Not Cooling...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$88.09 0.64 | 0.73%
05/17/13 - 04:02 PM ET
11.44M / 9.69M
Vol / Avg. Vol:87.47 / 87.45
Open / Prev. Close:87.41 - 88.20
Today's Range:61.71 - 87.88
52 Wk Range:25.66%
Performance YTD:TheStreet Rating:
Portfolios with JNJ
- Portfolio NameUser Type
- UserSlip's Portfolio
- Userralphd5-12
- ContributorStocks Fund Managers Love Q...
- ProGeorge Soros
- ContributorGame of Thrones Portfolio
- UserCapt Jer
- ContributorRocket Stocks for the Week ...
- ContributorShort Squeezes for the Week...
- UserQuicksilver55
- Userlennyvb Portfolio 1
Latest JNJ Headlines from TheStreet
- An Investor's Choice: J&J or Baxter International? 04.19.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Haves and Have-Nots 04.17.13 | 08:04 pm
- 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: ESRX URI BBBY JNJ WDAY TGT 04.17.13 | 12:04 pm
- 5 Stocks Fund Managers Love for 2013 04.17.13 | 11:04 am
- Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Bank Of America Corporation (BAC) Lags 04.17.13 | 10:04 am
- Google Offers Next Key Earnings Report 04.17.13 | 08:04 am
- Cramer's Top Stock Picks: KO JNJ GLD HK 04.17.13 | 06:04 am
- Dow Today: Johnson & Johnson (JNJ) Higher 04.16.13 | 11:04 am
- Morning Briefing: 10 Things You Should Know 04.16.13 | 08:04 am
Press Releases for JNJ
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
- Johnson & Johnson Comments On Venezuelan Currency Devaluation - PR Newswire 02.25.13 | 07:02 am
- Johnson & Johnson To Participate In 2013 Citi Global Health Care Conference - PR Newswire 02.20.13 | 09:02 am
- Johnson & Johnson To Participate In 2013 Leerink Swann Global Health Care Conference - PR Newswire 02.06.13 | 10:02 am
- Johnson & Johnson Presents Growth Strategies For Medical Devices & Diagnostics Segment - PR Newswire 01.22.13 | 09:01 am
Partner Headlines for JNJ
- Companies slide $181B through tax loopholes - MSN Money 04.19.13 | 10:04 am
- Protect Yourself From Gold - Seeking Alpha 04.19.13 | 08:04 am
- Market Close Report: NASDAQ Composite index closes at 3,204.67 down -59.96 points - NASDAQ 04.17.13 | 08:04 pm
- Abbott Labs' Q1 Earnings Steady After AbbVie Spinoff - Investor's Business Daily 04.17.13 | 04:04 pm
- Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013 - NASDAQ 04.17.13 | 01:04 pm
- Dow up 158 as stocks stage a 'never-mind' rally - MSN Money 04.17.13 | 11:04 am
- The Dip's Been Bought, Now Prepare Or Despair - Seeking Alpha 04.17.13 | 09:04 am
- US corporate earnings boost Wall St - Financial Times 04.16.13 | 09:04 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
